{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:28:18Z","timestamp":1780525698919,"version":"3.54.1"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341083"],"award-info":[{"award-number":["82341083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYYC23027"],"award-info":[{"award-number":["ZYYC23027"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYAI24016"],"award-info":[{"award-number":["ZYAI24016"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["RHM24208"],"award-info":[{"award-number":["RHM24208"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the risk factors in patients with drug-resistant tuberculosis (DR-TB) and clinical characteristics related to unfavorable anti-TB treatment outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 961 pulmonary tuberculosis (TB) patients were included at West China Hospital of Sichuan University from January 2008 to November 2023. We analyzed the differences of clinical characteristics between DR-TB and drug-sensitive tuberculosis (DS-TB), and then compared these features in DR-TB patients with different outcomes. Multivariable logistic regression models were employed to quantify risk factors associated with DR-TB and adverse treatment outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 961 pulmonary TB patients, a history of anti-TB treatment [odds ratio (OR), 3.289; 95% confidence interval (CI), 2.359\u20134.604] and CT-scan cavities (OR, 1.512; 95% CI, 1.052\u20132.168) increased DR-TB risk. A total of 214 DR-TB patients were followed for a median of 24.5 months. Among them, 116\/214 (54.2%) patients achieved favorable outcomes. Prior anti-TB treatment (OR, 1.927; 95% CI, 1.033\u20133.640), multidrug-resistant tuberculosis (MDR-TB) (OR, 2.558; 95% CI, 1.272\u20135.252), positive sputum bacteriology (OR, 2.116; 95% CI, 1.100\u20134.134), and pleural effusion (OR, 2.097; 95% CI, 1.093\u20134.082) were associated with unfavorable outcomes, while isoniazid-resistant TB patients showed better outcomes (OR, 0.401; 95% CI, 0.181\u20130.853). The clinical model for unfavorable outcome prediction of DR-TB achieved an area under the curve (AUC) of 0.754 (95% CI, 0.690\u20130.818).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Treatment history of anti-TB not only increases the risk of the emergence of DR-TB, but also potentially leads to treatment failure during re-treatment in DR-TB patients. Drug resistance subtypes, radiological characteristics, and the results of sputum smear or culture may affect the treatment outcome of DR-TB.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pcmedi\/pbaf008","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T01:35:37Z","timestamp":1745026537000},"source":"Crossref","is-referenced-by-count":3,"title":["Risk factors associated with morbidity and unfavorable treatment outcome in drug-resistant pulmonary tuberculosis: a case-control study"],"prefix":"10.1093","volume":"8","author":[{"given":"Changshu","family":"Li","sequence":"first","affiliation":[{"name":"Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, West China School of Medicine, Sichuan University Department of Pulmonary and Critical Care Medicine, , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufan","family":"Liang","sequence":"additional","affiliation":[{"name":"Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, West China School of Medicine, Sichuan University Department of Pulmonary and Critical Care Medicine, , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[{"name":"Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, West China School of Medicine, Sichuan University Department of Pulmonary and Critical Care Medicine, , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-1769","authenticated-orcid":false,"given":"Su","family":"Lui","sequence":"additional","affiliation":[{"name":"Huaxi MR Research Center (HMRRC), Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, West China Hospital, West China School of Medicine, Sichuan University Department of Radiology, and Functional and Molecular Imaging Key Laboratory of Sichuan Province, , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdi","family":"Wang","sequence":"additional","affiliation":[{"name":"Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, West China School of Medicine, Sichuan University Department of Pulmonary and Critical Care Medicine, , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"2025061604212879300_bib1","volume-title":"Global Tuberculosis Report","year":"2024"},{"key":"2025061604212879300_bib2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(24)00007-0","article-title":"Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021","volume":"24","author":"GBD 2021 Tuberculosis Collaborators","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025061604212879300_bib3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","article-title":"Tuberculosis","volume":"405","author":"Trajman","year":"2025","journal-title":"Lancet"},{"key":"2025061604212879300_bib4","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1016\/S1473-3099(24)00250-0","article-title":"Excess tuberculosis deaths in the WHO European region","volume":"24","author":"Burki","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025061604212879300_bib8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pccm.2024.08.008","article-title":"Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary disease","volume":"2","author":"Gai","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"2025061604212879300_bib9","doi-asserted-by":"publisher","first-page":"102406","DOI":"10.1016\/j.eclinm.2023.102406","article-title":"Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion","volume":"67","author":"van\u00a0der\u00a0Zalm","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2025061604212879300_bib10","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1002\/mco2.419","article-title":"Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention","volume":"5","author":"Zhuang","year":"2024","journal-title":"MedComm"},{"key":"2025061604212879300_bib11","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"2025061604212879300_bib12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02653-2","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2025061604212879300_bib13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","article-title":"Drug-resistant tuberculosis: a persistent global health concern","volume":"22","author":"Farhat","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"2025061604212879300_bib14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41590-024-01907-9","article-title":"Recasting resistance to Mycobacterium tuberculosis","volume":"25","author":"Andrews","year":"2024","journal-title":"Nat Immunol"},{"key":"2025061604212879300_bib15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/pcmedi\/pbaa041","article-title":"Strategies for advanced personalized tuberculosis diagnosis: current technologies and clinical approaches","volume":"4","author":"Chen","year":"2021","journal-title":"Precis Clin Med"},{"key":"2025061604212879300_bib17","doi-asserted-by":"publisher","first-page":"e2427266","DOI":"10.1001\/jamanetworkopen.2024.27266","article-title":"Recurrent pulmonary tuberculosis in China, 2005 to 2021","volume":"7","author":"Li","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025061604212879300_bib18","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"key":"2025061604212879300_bib19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40249-022-01009-4","article-title":"Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China,\u00a02006-2020","volume":"11","author":"Dong","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"2025061604212879300_bib21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1164\/rccm.202208-1475OC","article-title":"Assessing pretomanid for tuberculosis (APT), a randomized phase 2 trial of pretomanid-containing regimens for drug-sensitive tuberculosis: 12-week results","volume":"207","author":"Dooley","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2025061604212879300_bib22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cmi.2023.02.013","article-title":"Long-term treatment outcomes in patients with multidrug-resistant tuberculosis","volume":"29","author":"Maier","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","article-title":"Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles","volume":"19","author":"Li","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"2025061604212879300_bib24","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cmi.2023.07.013","article-title":"Recent advances in the treatment of tuberculosis","volume":"30","author":"Motta","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S2213-2600(23)00090-5","article-title":"Advances in tuberculosis control during the past decade","volume":"11","author":"Naidoo","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025061604212879300_bib26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.cmi.2024.06.016","article-title":"Candidate anti-tuberculosis medicines and regimens under clinical evaluation","volume":"30","author":"Hoelscher","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib27","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","article-title":"25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward","volume":"22","author":"Dean","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025061604212879300_bib28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijid.2019.02.004","article-title":"Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali","volume":"81","author":"Baya","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2025061604212879300_bib29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijid.2021.03.093","article-title":"Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events","volume":"107","author":"Bachir","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2025061604212879300_bib30","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jiph.2023.06.007","article-title":"Risk factors for multidrug-resistant tuberculosis in the Central African Republic: a case-control study","volume":"16","author":"de\u00a0Dieu\u00a0Longo","year":"2023","journal-title":"J Infect Public Health"},{"key":"2025061604212879300_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pulmoe.2023.09.003","article-title":"Occurrence and predictors of adverse events associated with linezolid in the treatment of patients with MDR-TB","volume":"30","author":"Oehadian","year":"2024","journal-title":"Pulmonology"},{"key":"2025061604212879300_bib32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cmi.2023.09.015","article-title":"Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"30","author":"Zhou","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jinf.2021.02.004","article-title":"Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey","volume":"82","author":"Wang","year":"2021","journal-title":"J Infect"},{"key":"2025061604212879300_bib34","doi-asserted-by":"publisher","first-page":"2101925","DOI":"10.1183\/13993003.01925-2021","article-title":"Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China","volume":"59","author":"Zheng","year":"2022","journal-title":"Eur Respir J"},{"key":"2025061604212879300_bib35","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1002\/mco2.487","article-title":"Deep learning for precise diagnosis and subtype triage of drug-resistant tuberculosis on chest computed tomography","volume":"5","author":"Liang","year":"2024","journal-title":"MedComm"},{"key":"2025061604212879300_bib36","doi-asserted-by":"publisher","first-page":"2100804","DOI":"10.1183\/13993003.00804-2021","article-title":"World Health Organization treatment outcome definitions for tuberculosis: 2021 update","volume":"58","author":"Linh","year":"2021","journal-title":"Eur Respir J"},{"key":"2025061604212879300_bib37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","article-title":"Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis","volume":"77","author":"Pradipta","year":"2018","journal-title":"J Infect"},{"key":"2025061604212879300_bib38","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB - latest developments in epidemiology, diagnostics and management","volume":"124 Suppl 1","author":"Tiberi","year":"2022","journal-title":"\u00a0Int J Infect Dis"},{"key":"2025061604212879300_bib39","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N Engl J Med"},{"key":"2025061604212879300_bib40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cmi.2023.12.001","article-title":"Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine","volume":"30","author":"Pedersen","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib41","doi-asserted-by":"publisher","first-page":"e0018019","DOI":"10.1128\/cmr.00180-19","article-title":"\u00a0The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives","volume":"35","author":"Dookie","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"2025061604212879300_bib42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","article-title":"Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis","volume":"87","author":"Pedersen","year":"2023","journal-title":"J Infect"},{"key":"2025061604212879300_bib43","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1016\/S2666-5247(23)00172-6","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study","volume":"4","author":"Derendinger","year":"2023","journal-title":"Lancet Microbe"},{"key":"2025061604212879300_bib44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025061604212879300_bib45","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1038\/s41467-019-11860-z","article-title":"Mycobacterial dynamin-like protein IniA mediates membrane fission","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"2025061604212879300_bib46","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1111\/bph.14867","article-title":"Isoniazid and host immune system interactions: a proposal for a novel comprehensive mode of action","volume":"176","author":"Khan","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2025061604212879300_bib47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S2213-2600(16)30433-7","article-title":"Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2025061604212879300_bib48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"key":"2025061604212879300_bib49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmi.2022.07.026","article-title":"Availability and costs of medicines for the treatment of tuberculosis in Europe","volume":"29","author":"G\u00fcnther","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib50","doi-asserted-by":"publisher","first-page":"119701","DOI":"10.1016\/j.cca.2024.119701","article-title":"Multidrug-resistant tuberculosis","volume":"559","author":"Wulandari","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2025061604212879300_bib51","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cmi.2020.07.004","article-title":"Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens","volume":"26","author":"Rivi\u00e8re","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib52","doi-asserted-by":"publisher","first-page":"2100783","DOI":"10.1183\/13993003.00783-2021","article-title":"Mycobacterium tuberculosis\u00a0borderline\u00a0rpoB\u00a0mutations: emerging from the unknown","volume":"58","author":"Van\u00a0Deun","year":"2021","journal-title":"Eur Respir J"},{"key":"2025061604212879300_bib53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2021.05.001","article-title":"Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance","volume":"30","author":"Laws","year":"2022","journal-title":"Trends Microbiol"},{"key":"2025061604212879300_bib54","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41467-025-56888-6","article-title":"Structural basis of siderophore export and drug efflux by Mycobacterium tuberculosis","volume":"16","author":"Earp","year":"2025","journal-title":"Nat Commun"},{"key":"2025061604212879300_bib55","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1038\/s41467-021-24151-3","article-title":"Allosteric drug transport mechanism of multidrug transporter AcrB","volume":"12","author":"Tam","year":"2021","journal-title":"Nat Commun"},{"key":"2025061604212879300_bib56","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1038\/s41467-024-51948-9","article-title":"Structures of the mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"2025061604212879300_bib57","doi-asserted-by":"publisher","first-page":"eaao1478","DOI":"10.1126\/sciadv.aao1478","article-title":"Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria","volume":"4","author":"Sakatos","year":"2018","journal-title":"Sci Adv"},{"key":"2025061604212879300_bib58","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/15548627.2024.2321831","article-title":"TRIM27 elicits protective immunity against tuberculosis by activating TFEB-mediated autophagy flux","volume":"7","author":"Zhao","year":"2024","journal-title":"Autophagy"},{"key":"2025061604212879300_bib59","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2147\/IDR.S300754","article-title":"A comparative study of chest computed tomography findings: 1030 cases of drug-sensitive tuberculosis versus 516 cases of drug-resistant tuberculosis","volume":"14","author":"Cheng","year":"2021","journal-title":"Infect Drug Resist"},{"key":"2025061604212879300_bib60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00330-022-08997-9","article-title":"Machine learning and radiomics for the prediction of multidrug resistance in cavitary pulmonary tuberculosis: a multicentre study","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radiol"},{"key":"2025061604212879300_bib61","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1038\/s41467-024-48691-6","article-title":"Distributable, metabolic PET reporting of tuberculosis","volume":"15","author":"Khan","year":"2024","journal-title":"Nat Commun"},{"key":"2025061604212879300_bib62","doi-asserted-by":"publisher","first-page":"907","DOI":"10.46234\/ccdcw2022.187","article-title":"Predictors for treatment outcomes in patients with multi-drug resistant tuberculosis - China, 2018-2020","volume":"4","author":"Zhang","year":"2022","journal-title":"China CDC Wkly"},{"key":"2025061604212879300_bib63","doi-asserted-by":"publisher","first-page":"2100361","DOI":"10.1183\/13993003.00361-2021","article-title":"New definitions of preextensively and extensively drug-resistant tuberculosis: update from the World Health Organization","volume":"57","author":"Viney","year":"2021","journal-title":"Eur Respir\u00a0J"},{"key":"2025061604212879300_bib64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"2025061604212879300_bib65","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S1473-3099(24)00263-9","article-title":"Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"24","author":"Schwab","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025061604212879300_bib16","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/S2666-5247(24)00131-9","article-title":"The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12\u00a0drugs in China from a nationwide survey: a genomic analysis","volume":"5","author":"Pei","year":"2024","journal-title":"Lancet Microbe"},{"key":"2025061604212879300_bib5","doi-asserted-by":"publisher","first-page":"731.e9","DOI":"10.1016\/j.cmi.2021.09.014","article-title":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025061604212879300_bib6","doi-asserted-by":"publisher","first-page":"pbae002","DOI":"10.1093\/pcmedi\/pbae002","article-title":"Radiomics-based quantitative contrast-enhanced CT analysis of abdominal lymphadenopathy to differentiate tuberculosis from lymphoma","volume":"7","author":"Shen","year":"2024","journal-title":"Precis Clin Med"},{"key":"2025061604212879300_bib7","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.xinn.2024.100648","article-title":"A multimodal integration pipeline for accurate diagnosis, pathogen identification, and prognosis prediction of pulmonary infections","volume":"5","author":"Shao","year":"2024","journal-title":"Innovation"},{"key":"2025061604212879300_bib66_779_035225","doi-asserted-by":"publisher","first-page":"e068576","DOI":"10.1136\/bmj-2021-068576","article-title":"Early identification of patients admitted to hospital for COVID-19 at risk of clinical deterioration: model development and multisite external validation study","volume":"376","author":"Kamran","year":"2022","journal-title":"BMJ"}],"container-title":["Precision Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pcm\/advance-article-pdf\/doi\/10.1093\/pcmedi\/pbaf008\/62955392\/pbaf008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pcm\/article-pdf\/8\/2\/pbaf008\/62955392\/pbaf008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pcm\/article-pdf\/8\/2\/pbaf008\/62955392\/pbaf008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:21:34Z","timestamp":1750062094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pcm\/article\/doi\/10.1093\/pcmedi\/pbaf008\/8116270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4,9]]}},"URL":"https:\/\/doi.org\/10.1093\/pcmedi\/pbaf008","relation":{},"ISSN":["2096-5303","2516-1571"],"issn-type":[{"value":"2096-5303","type":"print"},{"value":"2516-1571","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,9]]},"article-number":"pbaf008"}}